Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Alloxan Diabetes

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Alloxan Diabetes in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bishop, D; Cho, HR; Choi, SH; Doble, P; Hare, D; Jung, HS; Kim, KG; Kim, YJ; Lee, Y; Moon, WK; Park, KS1
Bonnet, PA; Chambon, C; Doucet, D; Fernandez, JP; Michel, A1

Other Studies

2 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Alloxan Diabetes

ArticleYear
Magnetic resonance imaging of the pancreas in streptozotocin-induced diabetic rats: Gadofluorine P and Gd-DOTA.
    World journal of gastroenterology, 2015, May-21, Volume: 21, Issue:19

    Topics: Animals; Area Under Curve; Biopsy; Contrast Media; Coordination Complexes; Diabetes Mellitus, Experimental; Female; Fluorocarbons; Heterocyclic Compounds; Magnetic Resonance Imaging; Organometallic Compounds; Pancreas; Predictive Value of Tests; Rats, Inbred F344; ROC Curve; Time Factors

2015
Pharmacokinetic study of gadolinium-DOTA in control and streptozocin diabetic rats.
    The Journal of pharmacy and pharmacology, 1992, Volume: 44, Issue:11

    Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Heterocyclic Compounds; Injections, Intravenous; Male; Organometallic Compounds; Rats; Rats, Wistar

1992